Abstract:Importance: Major depressive disorder (MDD) is an important risk factor of suicidal behavior, but the added burden of suicidal behavior and MDD on the patient and societal level, including all-cause mortality, is not well studied. Also, the contribution of various prognostic factors for suicidal behavior has not been quantified in larger samples. Objective: To describe the clinical and societal outcomes, including all-cause mortality, of suicidal behavior in patients with MDD and to explore associated risk factors and clinical management to inform future research and guidelines. Design, setting, and participants: This population-based cohort study used health care data from the Stockholm MDD Cohort. Patients aged 18 years or older with episodes of MDD diagnosed between January 1, 2012, and December 31, 2017, in any health care setting were included. The dates of the data analysis were February 1 to November 1, 2022. Exposures: Patients with MDD with and without records of suicidal behavior. Main outcomes and measures: The main outcome was all-cause mortality. Secondary outcomes were comorbid conditions, medications, health care resource utilization (HCRU), and work loss. Using Region Stockholm registry variables, a risk score for factors associated with suicidal behavior within 1 year after the start of an MDD episode was calculated. Results: A total of 158 169 unipolar MDD episodes were identified in 145 577 patients; 2240 (1.4%) of these episodes, in 2219 patients, included records of suicidal behavior (mean [SD] patient age, 40.9 [18.6] years; 1415 episodes [63.2%] in women and 825 [36.8%] in men). A total of 11 109 MDD episodes in 9574 matched patients with MDD without records of suicidal behavior were included as controls (mean [SD] patient age, 40.8 [18.5] years; 7046 episodes [63.4%] in women and 4063 [36.6%] in men). The all-cause mortality rate was 2.5 per 100 person-years at risk for the MDD-SB group and 1.0 per 100 person-years at risk for the MDD-non-SB group, based on 466 deaths. Suicidal behavior was associated with higher all-cause mortality (hazard ratio, 2.62 [95% CI, 2.15-3.20]), as well as with HCRU and work loss, compared with the matched controls. Patients with MDD and suicidal behavior were younger and more prone to have psychiatric comorbid conditions, such as personality disorders, substance use, and anxiety, at the start of their episode. The most important factors associated with suicidal behavior within 1 year after the start of an MDD episode were history of suicidal behavior and age, history of substance use and sleep disorders, and care setting in which MDD was diagnosed. Conclusions and relevance: This cohort study's findings suggest that high mortality, morbidity, HCRU, and work loss associated with MDD may be substantially accentuated in patients with MDD and suicidal behavior. Use of medication aimed at decreasing the risk of all-cause mortality during MDD episodes should be systematically evaluated to improve long-term outcomes.

Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden

Suicide Risk in Major Affective Disorder: Results from a National Survey in China.

Risk Factors for Recent Suicide Attempts in Major Depressive Disorder Patients in China: Results from a National Study

Prevalence and Clinical Features of Atypical Depression among Patients with Major Depressive Disorder in China.

Risk factors of suicidality in major depressive disorder patients with and without anxious characteristics

Gender Differences in Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with Major Depressive Disorder in China

Prescribing Patterns of Psychotropic Medications and Clinical Features in Patients with Major Depressive Disorder with and Without Comorbid Dysthymia in China

Major depressive disorder with suicidal ideation or behavior in Chinese population: A scoping review of current evidence on disease assessment, burden, treatment and risk factors

Prevalence of Suicidality in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Comparative Studies

A comparison of the clinical characteristics of women with recurrent major depression with and without suicidal symptomatology.

Perceived Stressfulness Mediates the Effects of Subjective Social Support and Negative Coping Style on Suicide Risk in Chinese Patients with Major Depressive Disorder.

Neuroimaging studies in major depressive disorder with suicidal ideation or behaviour among Chinese patients: implications for neural mechanisms and imaging signatures

Suicidal Risk Factors of Recurrent Major Depression in Han Chinese Women.

Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior.

Integrative analyses of scRNA-seq, bulk mRNA-seq, and DNA methylation profiling in depressed suicide brain tissues

Identifying clinical risk factors correlate with suicide attempts in patients with first episode major depressive disorder

Understanding the Complex of Suicide in Depression: from Research to Clinics

Prevalence of suicidality in clinically stable patients with major depressive disorder during the COVID-19 pandemic

Impact of moderate-to-high-suicide-intent in major depressive disorder: a retrospective cohort study on patient characteristics and healthcare resource utilisation in England

Determinants and Outcomes of Suicidal Behavior Among Patients With Major Depressive Disorder

Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries